By Counterforce Health Team in Hetlioz (tasimelteon) —

Do You Qualify for Hetlioz (Tasimelteon) Coverage by UnitedHealthcare in Virginia? Decision Tree & Next Steps

Answer Box: Your Fastest Path to Hetlioz Coverage

To get Hetlioz (tasimelteon) covered by UnitedHealthcare in Virginia, you must have a confirmed diagnosis of Non-24-Hour Sleep-Wake Disorder (with total blindness) or Smith-Magenis Syndrome, plus documented failure of melatonin therapy. The fastest approval path: (1) Have your sleep specialist complete UnitedHealthcare's prior authorization form with diagnosis codes and melatonin trial records, (2) Submit through the UnitedHealthcare Provider Portal or OptumRx, (3) If denied, request peer-to-peer review within 180 days. Virginia's external review process provides additional appeal rights through the State Corporation Commission Bureau of Insurance.

Table of Contents

  1. How to Use This Decision Tree
  2. Eligibility Triage: Do You Qualify?
  3. If "Likely Eligible": Your Action Plan
  4. If "Possibly Eligible": Tests and Timeline
  5. If "Not Yet": Alternatives and Exceptions
  6. If Denied: Virginia Appeal Path
  7. Coverage Requirements at a Glance
  8. Common Denial Reasons & Solutions
  9. Costs and Patient Assistance
  10. FAQ: Virginia-Specific Questions

How to Use This Decision Tree

This guide helps patients and clinicians navigate UnitedHealthcare's specific requirements for Hetlioz (tasimelteon) coverage in Virginia. Start with the eligibility triage below to determine your approval likelihood. Each section provides specific documents, deadlines, and next steps based on your situation.

Important: UnitedHealthcare processes Hetlioz through OptumRx specialty pharmacy, requiring prior authorization for both Non-24-Hour Sleep-Wake Disorder and Smith-Magenis Syndrome indications.

Eligibility Triage: Do You Qualify?

Likely Eligible ✅

You probably qualify if you have:

  • Confirmed diagnosis of Non-24-Hour Sleep-Wake Disorder AND total blindness (no light perception documented by ophthalmologist)
  • OR confirmed Smith-Magenis Syndrome with genetic testing (chromosome 17p11.2 deletion or RAI1 mutation)
  • Sleep specialist involvement in your care
  • Documented melatonin trial failure (minimum 6 months for most states; 30 days in Connecticut, Kentucky, Mississippi)
  • Age 16+ for Hetlioz capsules OR ages 3-15 for Hetlioz LQ oral suspension (SMS only)

Possibly Eligible ⚠️

You may qualify with additional documentation if you have:

  • Sleep-wake disorder symptoms but incomplete diagnosis workup
  • Melatonin intolerance or contraindication (shorter trial period accepted)
  • SMS diagnosis but missing genetic confirmation
  • Non-24 symptoms but unclear vision status

Not Yet Eligible ❌

You likely need alternative approaches if you have:

  • Circadian rhythm disorders other than Non-24 or SMS
  • Partial vision (any light perception) with Non-24 symptoms
  • No documented melatonin trial
  • Age under 3 years

If "Likely Eligible": Your Action Plan

Step-by-Step: Fastest Path to Approval

1. Gather Required Documentation (1-2 days)

  • Insurance card and member ID
  • Ophthalmology report confirming total blindness (for Non-24)
  • Genetic test results (for SMS)
  • Sleep specialist consultation notes
  • Melatonin trial records with dates, doses, and outcomes

2. Provider Submits Prior Authorization (Same day)

  • Complete UnitedHealthcare PA form (verify current link)
  • Submit via UnitedHealthcare Provider Portal or fax
  • Include all supporting clinical documentation

3. Track Authorization Status (1-5 business days)

  • Standard PA decisions: typically within 72 hours
  • Check status through provider portal
  • Urgent cases may qualify for expedited review
Clinician Corner: Your medical necessity letter should include: (1) specific diagnosis with ICD-10 code, (2) detailed melatonin trial history with exact dates and outcomes, (3) functional impact on patient's daily activities, (4) citation of FDA-approved indication, and (5) clear statement why Hetlioz is medically necessary for this patient.

If "Possibly Eligible": Tests and Timeline

Missing Diagnosis Documentation

For Non-24 Sleep-Wake Disorder:

  • Schedule ophthalmology evaluation to document total blindness
  • Complete 14-day sleep diary or actigraphy study
  • Sleep medicine consultation for formal diagnosis

For Smith-Magenis Syndrome:

  • Genetic testing for chromosome 17p11.2 deletion
  • Clinical genetics consultation
  • Document sleep disturbances specific to SMS

Insufficient Melatonin Trial

What UnitedHealthcare requires:

  • Minimum 6-month continuous trial (30 days in select states)
  • Documentation of specific doses used
  • Clear record of treatment failure or intolerance
  • Sleep specialist oversight of trial

Timeline to reapply: 2-8 weeks depending on needed tests

If "Not Yet": Alternatives and Exceptions

Alternative Treatments to Discuss

  • Ramelteon (Rozerem): Another melatonin receptor agonist, may have different coverage criteria
  • Over-the-counter melatonin: Higher doses or different formulations under specialist guidance
  • Light therapy: For appropriate candidates with circadian rhythm disorders

Exception Request Strategy

For off-label or exceptional circumstances, prepare:

  • Comprehensive medical necessity letter
  • Literature review supporting use
  • Documentation of failed standard therapies
  • Specialist attestation of unique clinical circumstances

If Denied: Virginia Appeal Path

Internal Appeals with UnitedHealthcare

First Level Appeal (180-day deadline)

  • Submit written appeal with denial letter
  • Include additional clinical documentation
  • Request peer-to-peer review with sleep specialist
  • Timeline: 30 days for standard, 72 hours for urgent

Second Level Appeal

  • Available if first appeal denied
  • Same documentation requirements
  • Final internal review before external options

Virginia External Review Process

When to Use External Review:

  • After completing UnitedHealthcare's internal appeals
  • Medical necessity or experimental treatment denials
  • 120 days from final internal denial to file

How to File:

  • Contact Virginia State Corporation Commission Bureau of Insurance at 1-877-310-6560
  • Complete Form 216-A External Review Request (verify current form)
  • Submit supporting documents within 5 business days

Timeline:

  • Standard review: 45 days
  • Expedited review: 72 hours (if doctor certifies urgency)
  • Decision is binding on UnitedHealthcare
From Our Advocates: We've seen successful appeals when providers submit comprehensive melatonin trial documentation showing specific doses, duration, and sleep diary evidence of continued circadian disruption. The key is demonstrating that standard therapy was truly inadequate, not just inconvenient.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required before dispensing UnitedHealthcare Provider Portal OptumRx PA Guidelines
Step Therapy Melatonin trial required first PA form section 3 UHC PA Form
Specialist Requirement Sleep medicine involvement Clinical documentation UHC Medical Policy
Age Restrictions 16+ for capsules, 3-15 for LQ FDA labeling FDA Access Data
Diagnosis Codes Non-24 or SMS specific ICD-10 in PA form Clinical documentation
Approval Duration 12 months Authorization letter UHC PA notification

Common Denial Reasons & Solutions

Denial Reason How to Overturn
"Diagnosis not confirmed" Submit ophthalmology report (Non-24) or genetic test (SMS)
"Step therapy not met" Provide detailed melatonin trial records with dates and outcomes
"Not medically necessary" Request peer-to-peer review; submit functional impact documentation
"Age/indication mismatch" Verify correct Hetlioz formulation (capsules vs. LQ) for patient age
"Missing specialist attestation" Sleep medicine consultation note confirming diagnosis and necessity

Costs and Patient Assistance

Typical Costs:

  • Hetlioz capsules: approximately $5,895 for 30-day supply
  • Hetlioz LQ: approximately $24,678 per bottle
  • Insurance coverage varies by plan tier and copay structure

Financial Assistance Options:

Coverage Tip: Counterforce Health helps patients and providers navigate complex prior authorization requirements and appeal denials with evidence-based documentation strategies.

FAQ: Virginia-Specific Questions

Q: How long does UnitedHealthcare prior authorization take in Virginia? A: Standard PA decisions typically within 72 hours; urgent cases may be expedited. Virginia law doesn't mandate specific PA timelines for commercial insurance, but UnitedHealthcare follows standard industry practices.

Q: What if Hetlioz is non-formulary on my plan? A: Non-formulary drugs require additional documentation but can be covered with medical necessity justification. Submit comprehensive clinical rationale and consider formulary exception request.

Q: Can I request expedited appeal in Virginia? A: Yes, if your doctor certifies that waiting could jeopardize your health. Both UnitedHealthcare internal appeals and Virginia external review offer expedited timelines.

Q: Does step therapy apply if I tried melatonin in another state? A: Yes, documented melatonin trials from any provider/location count toward UnitedHealthcare's step therapy requirement.

Q: What's the difference between internal and external appeals? A: Internal appeals are reviewed by UnitedHealthcare; external appeals are reviewed by independent medical experts through Virginia's State Corporation Commission process.

Q: Who can help me file an appeal in Virginia? A: Virginia's Bureau of Insurance Consumer Services (1-877-310-6560), your provider's office, or organizations like Counterforce Health that specialize in insurance appeals.

Disclaimer: This information is for educational purposes and doesn't constitute medical or legal advice. Insurance coverage varies by individual plan. Always verify current requirements with UnitedHealthcare and consult your healthcare provider for medical decisions.

For additional help with insurance issues in Virginia, contact the State Corporation Commission Bureau of Insurance at 1-877-310-6560 or visit scc.virginia.gov.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.